Collaboration to Implement Material Technologies in Innovative Printed Transistor Prototypes

Samsung Fine Chemicals Co., Ltd. and PARC, a Xerox company, today announced a client relationship to apply and implement novel material technologies of Samsung Fine Chemicals in innovative printed transistor prototypes. PARC will build on its vast expertise in printed transistors in order to demonstrate Samsung's breakthrough material offerings that will enable novel display products.

In Hee Sung, Samsung Fine Chemicals CEO commented, "PARC has a significant track record of not only technology innovation, but also in innovation that creates market and new business opportunities. PARC's experience in printed transistors along with their passionate team of researchers is a key success factor in this open innovation. We are very eager to see the fruits of this relationship and hope to make progress to capture this market in the future."

PARC and Samsung Fine Chemicals will combine their expertise in materials, printed electronics, and consumer devices, and incorporate their breadth of experience towards enabling new material offerings to be part of the next wave of innovative consumer products. The engagement will demonstrate that novel, advanced materials can be integrated into new and existing products.

"Samsung Fine Chemicals is a world-class company with global reach and superior products, and we are excited about our relationship with them to help them prototype devices based on their electronic materials," said Stephen Hoover, CEO, PARC. "This work we are doing with Samsung Fine Chemicals is another step toward deploying printed electronics into various consumer electronics applications and products. We're proud of our open innovation work with such a strong, established organization."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.